Target intelligence / Profile preview

Hepatocellular calcium signaling machinery

Molecular classification
Ion channel, Transporter, Receptor, Enzyme
01

Overview

The hepatocellular calcium signaling machinery is a complex network of proteins responsible for maintaining and utilizing calcium (Ca2+) as a second messenger to regulate liver-specific functions. Key components include the Inositol 1,4,5-trisphosphate receptor (IP3R) and Ryanodine receptor (RyR) for ER calcium release, the Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) for calcium reuptake, and Store-operated calcium entry (SOCE) mediated by STIM1 and Orai1 (Nathanson, 2022, Hepatology; Oliva-Vilarnau et al., 2018, Cell Calcium). This machinery orchestrates vital processes such as glucose and lipid metabolism, bile secretion, and hepatocyte regeneration (St-Pierre et al., 2016, Journal of Hepatology). In pathological states like hepatocellular carcinoma (HCC), the machinery is often remodeled, with upregulated SOCE components driving tumor cell proliferation, migration, and survival (Guéguinou et al., 2014, Oncotarget). While drugs like Sorafenib have been shown to indirectly affect this machinery by inducing ER stress and altering calcium flux, the system's broad physiological importance makes it a challenging therapeutic target (Zhang et al., 2017, Cancer Research). Therapeutic strategies often focus on specific components, such as Orai1 inhibitors, to achieve more selective modulation of the pathway in disease states.

Other names
Hepatic calcium signaling systemHepatocyte calcium toolkitLiver calcium signaling pathway
02

Mechanism of action

Modulation of intracellular calcium levels through the regulation of endoplasmic reticulum release channels, plasma membrane entry channels, and active transport pumps.

03

Biological functions

Signal transductionMetabolismBile secretionCell proliferationApoptosis
04

Disease associations

Hepatocellular carcinomaNonalcoholic fatty liver diseaseLiver fibrosisCholestasis
05

Safety considerations

Systemic toxicity due to the ubiquitous role of calcium in cardiac and neuronal functionPotential for disrupting global metabolic homeostasisDifficulty in achieving hepatocyte-specific targeting
06

Interacting drugs

Sorafenib

3 more in the full profile.

07

Biomarkers

Orai1 expression levelsSTIM1 expression levelsCytosolic calcium oscillation frequency

Beyond the preview

Go deeper on Hepatocellular calcium signaling machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatocellular calcium signaling machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call